The marker "CD16+ or CD56+/ CD3+" refers to a subset of immune cells that express CD16 or CD56 surface proteins along with CD3. These markers are typically associated with a specific type of T cell known as NKT (Natural Killer T) cells. NKT cells are unique because they share properties of both NK cells and conventional T cells, playing a versatile role in the immune system. CD16 and CD56: These are markers commonly found on NK cells, which are part of the innate immune system. CD16 is a receptor that allows these cells to recognize and destroy antibody-coated target cells, while CD56 is an adhesion molecule that facilitates cell-cell interactions and migration. CD3: This is a marker that is characteristic of T cells, specifically associated with the T-cell receptor (TCR) complex. The presence of CD3 indicates that these cells have T-cell lineage, allowing them to participate in adaptive immune responses. When immune cells are "CD16+ or CD56+ CD3+", it implies they are a specialized subset that can respond quickly to infected or transformed cells, combining the rapid, non-specific response typical of NK cells with the specific, adaptive responses characteristic of T cells. These cells play roles in immune regulation, autoimmune disease responses, cancer surveillance, and infection defense. Understanding the presence and levels of CD16+ or CD56+ CD3+ cells can provide insights into the state of the immune system, especially in contexts such as autoimmune diseases, cancer immunology, and infectious diseases.
The marker "CD16+ or CD56+/ CD3+" refers to a subset of immune cells that express CD16 or CD56 surface proteins along with CD3. These markers are typically associated with a specific type of T cell known as NKT (Natural Killer T) cells. NKT cells are unique because they share properties of both NK cells and conventional T cells, playing a versatile role in the immune system. CD16 and CD56: These are markers commonly found on NK cells, which are part of the innate immune system. CD16 is a receptor that allows these cells to recognize and destroy antibody-coated target cells, while CD56 is an adhesion molecule that facilitates cell-cell interactions and migration. CD3: This is a marker that is characteristic of T cells, specifically associated with the T-cell receptor (TCR) complex. The presence of CD3 indicates that these cells have T-cell lineage, allowing them to participate in adaptive immune responses. When immune cells are "CD16+ or CD56+ CD3+", it implies they are a specialized subset that can respond quickly to infected or transformed cells, combining the rapid, non-specific response typical of NK cells with the specific, adaptive responses characteristic of T cells. These cells play roles in immune regulation, autoimmune disease responses, cancer surveillance, and infection defense. Understanding the presence and levels of CD16+ or CD56+ CD3+ cells can provide insights into the state of the immune system, especially in contexts such as autoimmune diseases, cancer immunology, and infectious diseases.
an important NK (Natural killer) cell subset.
LEUKOCYTE ADHESION DEFICIENCY (CD15S,CD18)
a protein found on the surface of B-cells
a protein found on the surface of B-cells
Total circulating B cells
Percent of B cells
Naive B cells CD19+CD27-CD21-CD38- are a specific subset of B cells with distinct surface marker characteristics: CD19+: This marker indicates that these cells express the CD19 antigen, which is commonly found on B cells. CD27-: The absence of CD27 expression suggests that these B cells are not memory B cells. CD27 is typically expressed on memory B cells. CD21-: The absence of CD21 expression may indicate that these B cells have reduced levels of complement receptor 2 (CR2), which can affect their ability to respond to complement-mediated signals. CD38-: The absence of CD38 expression suggests that these B cells have lower levels of CD38, which is involved in various B cell functions, including activation and differentiation. The term "naive" implies that these B cells have not yet encountered and been activated by antigens. They are considered to be in an immature state and are ready to respond to new antigens when encountered. The term "(% Pos of B)" likely refers to the percentage of these naive B cells within the total population of B cells in a given sample or context. The exact percentage can vary depending on the individual and the specific experimental conditions.
a subset of B cells that have not yet encountered an antigen
CD19+CD27+IgM+IgD+ refers to a specific subset of B cells characterized by the expression of the cell surface markers CD19, CD27, IgM, and IgD. These markers help categorize B cells into different subsets based on their developmental stage and function. In this context, the percentage of CD19+CD27+IgM+IgD+ cells (% of CD27+) likely refers to the proportion of B cells with this specific phenotype within the total CD27+ B cell population. It represents a subset of memory B cells with unique characteristics. Research suggests that CD27+IgD+ B cells, also known as IgM memory B cells, are distinct from other B cell subsets and may play a role in immune responses. They have been associated with certain conditions, such as common variable immunodeficiency (CVID), where their levels may be altered compared to healthy individuals. The exact percentage can vary among individuals and may have implications for understanding immune function and response in different contexts. However, the specific percentage may not be provided in the provided search results. To determine the exact percentage, laboratory testing or research studies would be needed. Naive B cells, specifically CD19+CD27+IgM+IgD+ B cells, represent a subset of B lymphocytes in the immune system. Here's more details on the different populations: CD27 Expression: CD27 is a cell surface marker used to distinguish between different B cell populations. In humans, CD27 expression helps differentiate between memory and naive B cells. Naive B cells typically have low levels of CD27 expression, while memory B cells have higher levels. IgM and IgD Expression: CD19+CD27+IgM+IgD+ indicates that these B cells express both IgM and IgD immunoglobulins, which are antigen receptors on B cells. This expression pattern is characteristic of naive or less-differentiated B cells. Percentage of CD27+: The term "CD19+CD27+IgM+IgD+ (% of CD27+)" suggests that you are looking for the proportion of CD27+ B cells that express CD19, IgM, and IgD. This percentage would represent the subset of CD27+ B cells that exhibit the naive B cell phenotype. Naive B cells with the CD19+CD27+IgM+IgD+ phenotype are a subset of B cells with low CD27 expression and the presence of both IgM and IgD. The percentage of these cells within the CD27+ B cell population may vary depending on the individual and their immune status, but they are typically considered less differentiated and play a role in the initial immune response to new antigens.
a cell surface protein primarily expressed on the surface of B-cells
Mature B-cell marker
a critical surface marker
The CD3-/CD16+CD56+ (%) test is a sophisticated diagnostic assay crucial in the field of immunology, offering invaluable insights into the functioning of the body’s immune system. This test specifically measures the percentage of natural killer (NK) cells, identified by the absence of CD3 and the presence of CD16 and CD56 markers, in the total lymphocyte population. NK cells are a vital component of the innate immune system, playing a key role in the body’s first line of defense against tumors, virally infected cells, and in modulating immune responses. The CD3-/CD16+CD56+ (%) test is pivotal in evaluating various immune conditions, including autoimmune diseases, chronic viral infections, and certain cancers. In oncology, alterations in the percentage of these NK cells can provide insights into tumor immunology and the body's natural ability to combat cancer. In autoimmune diseases, aberrant levels of NK cells may reflect dysregulation in the immune system. Additionally, this test holds significance in the study of reproductive health, as NK cells are involved in pregnancy, particularly in the implantation process and early placental development. High levels of NK cells are often explored in cases of recurrent miscarriages and fertility issues. Conversely, a reduced percentage of NK cells may indicate a compromised immune system.
absolute count of Natural Killer (NK) cells
The marker "CD3/CD8/CD45RO" is used in immunological studies to identify and characterize a specific subset of T cells known as memory T cells. CD3 is a marker found on all T cells, indicating their role in the immune system, while CD8 is present on cytotoxic T cells, which are responsible for directly killing infected or cancerous cells. CD45RO is a marker that distinguishes memory T cells from naive T cells; it indicates that these cells have previously encountered an antigen and are primed for a faster and more efficient response upon re-exposure. Elevated levels of CD3/CD8/CD45RO cells may indicate an ongoing immune response or prior exposure to an antigen, suggesting the presence of infections, chronic inflammatory conditions, or autoimmune disorders. Understanding the levels and activity of these memory T cells can provide valuable insights into the body's immune status, helping healthcare providers tailor treatments for infections, immune disorders, and even cancer.
The marker "CD3/gamma-delta" on a T Cell Monitoring & Activation panel refers to a unique subset of T cells known as gamma-delta T cells. These cells are characterized by their T-cell receptor (TCR) composition, which includes a gamma chain and a delta chain, distinguishing them from the more common alpha-beta T cells, which have alpha and beta chains in their TCRs. Gamma-delta T cells are a critical component of the immune system, bridging the gap between innate and adaptive immunity. Unlike conventional alpha-beta T cells, gamma-delta T cells can recognize antigens without the need for presentation by major histocompatibility complex (MHC) molecules, allowing for a rapid response to a wide range of pathogens, including bacteria, viruses, and tumors. They are commonly found in mucosal tissues such as the gut, skin, and respiratory tract, where they serve as a first line of defense. Gamma-delta T cells also play a role in immune surveillance and tissue homeostasis, producing cytokines and growth factors that influence other immune cells. Elevated or altered levels of CD3/gamma-delta T cells can indicate various pathological conditions, including infections, autoimmune diseases, and cancers. Monitoring these cells can provide valuable insights into the state of the immune system and the body's response to disease, making CD3/gamma-delta a significant marker in immunological research and clinical diagnostics. Their unique characteristics and versatile roles make them a subject of interest for potential therapeutic interventions, particularly in the fields of cancer immunotherapy and infectious disease management.
CD3 cells are total T lymphocytes
The biomarker CD3+/CD4-/CD8- identifies a unique subset of T lymphocytes that express the CD3 surface protein but lack both CD4 and CD8 co-receptors. These cells are often referred to as double-negative T cells (DN T cells) due to their absence of CD4 and CD8 expression. DN T cells represent a small fraction of the total T cell population in peripheral blood, typically accounting for less than 5% of T cells. Despite their rarity, these cells play important roles in immune regulation and have been implicated in various autoimmune diseases, transplant rejection, and cancer immunology. DN T cells can exhibit both immunosuppressive and pro-inflammatory functions, depending on the context. They are capable of producing cytokines and can have cytotoxic activity. The CD3+/CD4-/CD8- phenotype is typically assessed using flow cytometry, which allows for precise identification and quantification of this cell population. Alterations in the frequency or function of DN T cells may serve as indicators of immune dysregulation or specific disease states.f